Encouraging news in genomics investments, and perhaps a bit of the shine has come off bioinformatics? While the field of bioinformatics is increasingly becoming the essential core of molecular biology, the business model is still at the blastula stage: From GenomeWeb:
Venture capital investment in the genomics, bioinformatics, and proteomics segments increased five-fold during the fourth quarter of 2006 over the same period in 2005, according to a GenomeWeb Daily News roundup of companies that disclosed receiving investments. Venture capitalists invested around $140 million in genome tool and technology companies in the final quarter of 2006, nearly 5 times the $31.6 million they invested in the same period of 2005. Private-equity investors flocked to genomics businesses, while venture funding among bioinformatics companies dipped slightly. Investors spent $70 million on companies with core businesses in genomics during the fourth quarter of 2006, almost 5 times more than the $15.2 million they spent year over year. Venture funding for businesses focused on bioinformatics over the period declined 4.4 percent to $13 million from $13.6 million in the same quarter in 2005.